Search Results - "Larusso, Domenica"

Activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab or panitumumab in patients with refractory solid tumors by Garralda, Elena, Del Conte, Gianluca, Macchini, Marina, Matos, Ignacio, Klinghammer, Konrad Friedrich, Saavedra Santa Gadea, Omar, Fiedler, Walter M., Rolling, Christina C, Kebenko, Maxim, Raspagliesi, Francesco, Larusso, Domenica, ahrens-Fath, Isabelle, Habel, Beate, Baumeister, Hans, Zurlo, Alfredo, Ochsenreither, Sebastian

“…Abstract only 2522 Background: The phase I GATTO study explored the feasibility, tolerability and preliminary activity of combining Gatipotuzumab (GAT), a…”
Get full text

Safety and tolerability results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab or panitumumab in patients with refractory solid tumors by Ochsenreither, Sebastian, Zurlo, Alfredo, Garralda, Elena, Matos, Ignacio, Klinghammer, Konrad Friedrich, Del Conte, Gianluca, Macchini, Marina, Rolling, Christina C, Kebenko, Maxim, Saavedra Santa Gadea, Omar, Raspagliesi, Francesco, Larusso, Domenica, ahrens-Fath, Isabelle, Habel, Beate, Baumeister, Hans, Fiedler, Walter M.

“…Abstract only 2524 Background: The phase I GATTO study explored the feasibility, tolerability and preliminary activity of combining gatipotuzumab (GAT), a…”
Get full text

Surgical and systemic management of endometrial cancer: an international survey by Fotopoulou, Christina, Kraetschell, Robert, Dowdy, Sean, Fujiwara, Keiichi, Yaegashi, Nobuo, Larusso, Domenica, Casado, Antonio, Mahner, Sven, Herzog, Thomas J., Kehoe, Sean, Vergote, Ignace, Miller, David Scott, Marth, Christian, Fujii, Shingo, Sehouli, Jalid

“…Purpose To ascertain the spectrum of clinical management of endometrial carcinoma (EC) the largest international survey was conducted to evaluate and identify…”
Get full text